Division of Nuclear Medicine, St Luke's Roosevelt Hospital Center, New York, NY 10025, USA.
Clin Nucl Med. 2009 Dec;34(12):845-7. doi: 10.1097/RLU.0b013e3181becf3f.
We report a case of a 57-year-old postmenopausal woman with an autonomously functioning thyroid adenoma spontaneously developing Graves' disease (GD) as documented by I-123 scintigraphy. To date, anecdotal case reports citing the progression of an autonomous nodule to GD have documented either a major thyroidal insult, spontaneous or therapeutic, or the activation of thyroid tissue by circulating thyroid stimulating IgG, with variable progression characteristics. In contradiction to the proposed inciting factors, our patient underwent a minimally invasive fine needle aspiration biopsy followed by suppressive pharmacotherapy. Her antithyroid antibody assay detected low titers of thyroperoxidase antibody (<10 U/mL). We conclude that this is a rare case of autonomously functioning adenoma where neither significant thyroid tissue damage nor the presence of thyroid stimulating IgG can be implicated as an inciting trigger in its progression to GD.
我们报告了一例 57 岁绝经后妇女,其自主功能性甲状腺腺瘤在 I-123 闪烁扫描中自发发展为 Graves 病(GD)。迄今为止,有一些病例报告指出,自主结节向 GD 的进展记录了要么是甲状腺的重大损伤,无论是自发性的还是治疗性的,要么是循环甲状腺刺激 IgG 激活了甲状腺组织,具有不同的进展特征。与所提出的诱发因素相反,我们的患者接受了微创细针抽吸活检,随后进行了抑制性药物治疗。她的抗甲状腺抗体检测发现甲状腺过氧化物酶抗体滴度较低(<10 U/mL)。我们得出结论,这是一例罕见的自主功能性腺瘤病例,其中没有明显的甲状腺组织损伤,也没有甲状腺刺激 IgG 的存在,可以作为其向 GD 进展的诱发因素。